30岁以下女性BI-RADS 3类病变的随访结局与活检相关因素
回顾性分析2013年1月1日至2015年1月1日215例30岁以下女性278个BI-RADS 3类病变,活检率24%,恶性率0%(95%CI 0-1.7%),直径>2 cm病变即刻活检的OR为4.4(95%CI 2.1-9.4,P<.01)。作者认为年轻女性可能为纤维腺瘤的病变或许仅需6个月短期随访。
要点
- 30岁以下女性BI-RADS 3类病变恶性率为0%(95%CI 0-1.7%)。
- 直径>2 cm病变即刻活检OR为4.4(95%CI 2.1-9.4,P<.01)。
- 活检更多因患者要求而非病变生长(63.4% vs 36.5%,P<.01)。
诊断标准与关键数值
- 本队列恶性率为0%(95%CI 0-1.7%)。
- 直径>2 cm病变即刻活检的OR为4.4(95%CI 2.1-9.4,P<.01)。
临床应用与阅片要点
- 215例女性中52例(24%)接受活检,因患者要求33例(63.4%)多于因病变生长19例(36.5%),P<.01。
- 预期随访影像的188例女性中,58例(30%)失访,103例(55%)完成6个月随访,74例(39%)完成12个月随访,56例(30%)完成24个月随访。
局限性
- 本研究为回顾性研究。
- 本队列随访依从性低,188例预期随访女性中58例(30%)失访。
- 作者结论使用「suggest」「may」,提示需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Investigate imaging follow-up patterns and assessment of malignancy rate of BI-RADS 3 lesions in women younger than 30 years.
METHODS: We retrospectively reviewed consecutive studies between January 1, 2013 and January 1, 2015 with BI-RADS 3 assessment in women <30 years. Lesion size, follow-up rate, and biopsy rate were recorded. Completion of 24-month imaging follow-up or biopsy determined the endpoint. Statistical analysis of follow-up rates and biopsy timing was performed.
RESULTS: Of 2525 BI-RADS 3 lesions, 278 were identified in 215 women <30 years. Fifty-two (24%) women underwent a biopsy which was more frequently done at patient request than for lesion growth [33 (63.4%) versus 19 (36.5%), P <.01]. The odds of having biopsy upfront was significantly higher in lesions >2 cm in diameter (OR: 4.4 [95% CI 2.1-9.4], P <.01). The malignancy rate in our cohort was 0% (95% CI 0-1.7%). Of the 188 women expected for follow-up imaging, 58 (30%) were lost to follow-up, while 103 (55%) had 6-month follow-up, 74 (39%) 12-month follow-up, and 56 (30%) 24-month follow-up.
CONCLUSIONS: BI-RADS 3 lesions identified in our cohort had high biopsy rates and low compliance with no cancers. Our findings suggest that probable fibroadenomas in young women may only warrant abbreviated short-term follow-up at 6-months.
引用
- Merchant K, Omar L, Hayes J, et al. ACR BI-RADS Category 3 Lesions in Women Younger Than 30: Follow-up Outcomes and Factors Associated With Biopsy. J Ultrasound Med. 2021. PMID: 33599304. doi:10.1002/jum.15660
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。